Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Daniel Bets"'
Autor:
Daniel Bets, Jolien de Jager, Ab J.M. Donker, M G Wulffelé, Philippe Lehert, Adriaan Kooy, Coen D.A. Stehouwer
Publikováno v:
Archives of internal medicine, 169(6), 616-625. American Medical Association
Kooy, A, de Jager, J, Lehert, P, Bets, D, Wulffele, M G, Donker, A J M & Stehouwer, C D A 2009, ' Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus ', Archives of Internal Medicine, vol. 169, no. 6, pp. 616-625 . https://doi.org/10.1001/archinternmed.2009.20
Archives of Internal Medicine, 169(6), 616-625. American Medical Association
Archives of Internal Medicine, 169(6), 616-25. AMA
Kooy, A, de Jager, J, Lehert, P, Bets, D, Wulffele, M G, Donker, A J M & Stehouwer, C D A 2009, ' Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus ', Archives of Internal Medicine, vol. 169, no. 6, pp. 616-625 . https://doi.org/10.1001/archinternmed.2009.20
Archives of Internal Medicine, 169(6), 616-625. American Medical Association
Archives of Internal Medicine, 169(6), 616-25. AMA
BACKGROUND: We investigated whether metformin hydrochloride has sustained beneficial metabolic and (cardio) vascular effects in patients with type 2 diabetes mellitus (DM2). METHODS: We studied 390 patients treated with insulin in the outpatient clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8da1a1b9ccc79681e5904f1d50290c5
https://doi.org/10.1001/archinternmed.2009.20
https://doi.org/10.1001/archinternmed.2009.20
Autor:
A. J. M. Donker, Bob Borger van der Burg, Daniel Bets, M G Wulffelé, Jeles C. Ogterop, Philippe Lehert, Coen D.A. Stehouwer, Adriaan Kooy
Publikováno v:
Diabetes Care. 25:2133-2140
OBJECTIVE—To investigate the metabolic effects of metformin, as compared with placebo, in type 2 diabetic patients intensively treated with insulin. RESEARCH DESIGN AND METHODS—Metformin improves glycemic control in poorly controlled type 2 diabe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6f3ecf7cd94ea78fc5a72bc68c6040a
https://doi.org/10.2337/diacare.25.12.2133
https://doi.org/10.2337/diacare.25.12.2133
Autor:
Adriaan Kooy, Philippe Lehert, M G Wulffelé, Jan van der Kolk, Jolien de Jager, Daniel Bets, Joop Verburg, Coen D.A. Stehouwer, Ab J.M. Donker
Publikováno v:
de Jager, J, Kooy, A, Lehert, P, Wulffele, M, van der Kolk, J, Bets, D, Verburg, J, Donker, A J M & Stehouwer, C D A 2010, ' Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial ', British Medical Journal, vol. 340, pp. c2181 . https://doi.org/10.1136/bmj.c2181
British Medical Journal, 340
BMJ, 340:2181. British Medical Journal
The BMJ
BMJ (Clinical research ed.), 340. British Medical Association
BMJ : British medical journal, 340. British Medical Association
British Medical Journal, 340
BMJ, 340:2181. British Medical Journal
The BMJ
BMJ (Clinical research ed.), 340. British Medical Association
BMJ : British medical journal, 340. British Medical Association
OBJECTIVES: To study the effects of metformin on the incidence of vitamin B-12 deficiency (220 pmol/l). CONCLUSIONS: Long term treatment with metformin increases the risk of vitamin B-12 deficiency, which results in raised homocysteine concentrations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b16ce3fb08c0d9f756f4dd134ab42a76
https://pubmed.ncbi.nlm.nih.gov/20488912
https://pubmed.ncbi.nlm.nih.gov/20488912